Crossref
journal-article
Public Library of Science (PLoS)
PLoS Pathogens (340)
References
66
Referenced
61
10.1056/NEJM199709113371102
/ N Engl J Med / Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy by RM Gulick (1997)10.1056/NEJM199709113371101
/ N Engl J Med / A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team by SM Hammer (1997)10.1038/35073673
/ Nature / HIV chemotherapy by DD Richman (2001)10.1086/505147
/ J Infect Dis / The survival benefits of AIDS treatment in the United States by RP Walensky (2006)10.1016/j.antiviral.2009.09.009
/ Antiviral Res / Novel approaches to inhibiting HIV-1 replication by CS Adamson (2010)10.1517/14728220903039714
/ Expert Opin Ther Targets / Virus maturation as a new HIV-1 therapeutic target by CS Adamson (2009)10.1006/viro.1998.9398
/ Virology / HIV-1 Gag proteins: diverse functions in the virus life cycle by EO Freed (1998)10.1016/j.sbi.2008.02.001
/ Curr Opin Struct Biol / The structural biology of HIV assembly by BK Ganser-Pornillos (2008)10.1089/aid.1989.5.577
/ AIDS Res Hum Retroviruses / Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease by S Erickson-Viitanen (1989)10.1074/jbc.M112.339374
/ J Biol Chem / Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease by SK Lee (2012)10.1128/JVI.65.2.922-930.1991
/ J Virol / Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein by RJ Tritch (1991)10.1126/science.283.5398.80
/ Science / Assembly and analysis of conical models for the HIV-1 core by BK Ganser (1999)10.1038/35030177
/ Nature / Image reconstructions of helical assemblies of the HIV-1 CA protein by S Li (2000)10.1128/JVI.69.7.4213-4227.1995
/ J Virol / Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein by RC Craven (1995)10.1128/JVI.68.12.8180-8187.1994
/ J Virol / Functional domains of the capsid protein of human immunodeficiency virus type 1 by T Dorfman (1994)10.1128/JVI.70.8.5106-5114.1996
/ J Virol / Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents by J McDermott (1996)10.1126/science.278.5339.849
/ Science / Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein by TR Gamble (1997)10.1128/JVI.75.15.6850-6856.2001
/ J Virol / Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions by JB Bowzard (2001)10.1128/JVI.75.1.242-250.2001
/ J Virol / Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants by TM Cairns (2001)10.1016/j.jmb.2007.05.020
/ J Mol Biol / Mutations in capsid major homology region affect assembly and membrane affinity of HIV-1 Gag by YF Chang (2007)10.1021/bi9606399
/ Biochemistry / The major homology region of the HIV-1 gag precursor influences membrane affinity by D Ebbets-Reed (1996)10.1128/JVI.68.8.4927-4936.1994
/ J Virol / Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis by F Mammano (1994)10.1128/JVI.00214-08
/ J Virol / Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly by JG Purdy (2008)10.1128/JVI.66.12.7021-7032.1992
/ J Virol / Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis by C Strambio-de-Castillia (1992)10.1128/JVI.77.9.5439-5450.2003
/ J Virol / Functional surfaces of the human immunodeficiency virus type 1 capsid protein by UK von Schwedler (2003)10.1099/0022-1317-78-3-637
/ J Gen Virol / The major homology region of bovine leukaemia virus p24gag is required for virus infectivity in vivo by L Willems (1997)10.1110/ps.041087605
/ Protein Sci / Helical structure determined by NMR of the HIV-1 (345–392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging by N Morellet (2005)10.1038/sj.emboj.7601664
/ EMBO J / Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells by ER Wright (2007)10.1128/JVI.72.3.2072-2078.1998
/ J Virol / A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly by MA Accola (1998)10.1128/JVI.00006-11
/ J Virol / On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? by SA Datta (2011)10.1128/JVI.79.3.1803-1812.2005
/ J Virol / Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag by X Guo (2005)10.1128/JVI.69.6.3407-3419.1995
/ J Virol / The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity by HG Krausslich (1995)10.1016/j.virol.2006.07.023
/ Virology / Determinants of activity of the HIV-1 maturation inhibitor PA-457 by F Li (2006)10.1128/JVI.76.22.11729-11737.2002
/ J Virol / Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 Gag by C Liang (2002)10.1021/np50104a008
/ J Nat Prod / Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids by T Fujioka (1994)10.1128/AAC.45.4.1225-1230.2001
/ Antimicrob Agents Chemother / Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation by T Kanamoto (2001)10.1021/jm950922q
/ J Med Chem / Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents by Y Kashiwada (1996)10.1073/pnas.2234683100
/ Proc Natl Acad Sci U S A / PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing by F Li (2003)10.1128/JVI.78.2.922-929.2004
/ J Virol / Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation by J Zhou (2004)10.1128/JVI.01369-06
/ J Virol / In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat) by CS Adamson (2006)10.1128/JVI.02659-08
/ J Virol / Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457) by CS Adamson (2009)10.1074/jbc.M508951200
/ J Biol Chem / Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles by J Zhou (2005)10.1128/JVI.01626-06
/ J Virol / Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3′,3′-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag by J Zhou (2006)10.1128/JVI.02743-05
/ J Virol / 3-O-(3′,3′-dimethysuccinyl) betulinic acid inhibits maturation of the human immunodeficiency virus type 1 Gag precursor assembled in vitro by M Sakalian (2006)10.1186/1742-4690-8-101
/ Retrovirology / The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles by AT Nguyen (2011)10.1177/095632020801900301
/ Antivir Chem Chemother / Bevirimat: a novel maturation inhibitor for the treatment of HIV-1 infection by DE Martin (2008)10.1128/AAC.00152-07
/ Antimicrob Agents Chemother / Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3′,3′-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection by PF Smith (2007)- McCallister S, Lalezari J, Richmond G, Thompson M, Harrigan R, <etal>et al</etal>.. (2008) HIV-1 Gag Polymorphisms Determine Treatment Response to Bevirimat (PA-457). In: Proceedings of the XVII International HIV Drug Resistance Workshop; 10–14 June 2008; Sitges, Spain.
10.1097/QAD.0b013e328335ce07
/ AIDS / High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor by E Seclen (2010)10.1128/AAC.01650-08
/ Antimicrob Agents Chemother / HIV-1 Susceptibility to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag SP1 by K Van Baelen (2009)10.1186/1742-4690-7-36
/ Retrovirology / Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat by CS Adamson (2010)10.1128/AAC.01435-10
/ Antimicrob Agents Chemother / A single polymorphism in HIV-1 subtype C SP1 is sufficient to confer natural resistance to the maturation inhibitor bevirimat by W Lu (2011)10.1128/AAC.00759-09
/ Antimicrob Agents Chemother / New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation by WS Blair (2009)10.1128/JVI.01926-10
/ J Virol / HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice by PW Keller (2010)10.1128/JVI.68.8.5311-5320.1994
/ J Virol / Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production by EO Freed (1994)10.1128/JVI.74.11.5142-5150.2000
/ J Virol / Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding by A Ono (2000)10.1128/JVI.73.5.4136-4144.1999
/ J Virol / Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus by A Ono (1999)10.1128/JVI.74.6.2855-2866.2000
/ J Virol / Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly by A Ono (2000)10.1128/JVI.79.22.14131-14140.2005
/ J Virol / Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay by A Ono (2005)10.1021/bi902196e
/ Biochemistry / NMR relaxation studies of an RNA-binding segment of the rous sarcoma virus gag polyprotein in free and bound states: a model for autoinhibition of assembly by GM Taylor (2010)10.1038/nature11169
/ Nature / Structure of the immature retroviral capsid at 8 A resolution by cryo-electron microscopy by TA Bharat (2012)- Waheed AA, Ono A, Freed EO (2009) Methods for the study of HIV-1 assembly. In: HIV Protocols, second edition. p. 163–184.
10.1021/bc0200529
/ Bioconjug Chem / Synthesis of linear polyethylenimine derivatives for DNA transfection by B Brissault (2003)10.1128/JVI.59.2.284-291.1986
/ J Virol / Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone by A Adachi (1986)10.1128/JVI.68.4.2503-2512.1994
/ J Virol / Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120 by EO Freed (1994)10.1016/j.cell.2009.04.063
/ Cell / X-ray structures of the hexameric building block of the HIV capsid by O Pornillos (2009)
Dates
Type | When |
---|---|
Created | 12 years, 9 months ago (Nov. 8, 2012, 5:20 p.m.) |
Deposited | 5 years, 1 month ago (July 15, 2020, 5:01 p.m.) |
Indexed | 1 month ago (July 23, 2025, 8:56 a.m.) |
Issued | 12 years, 9 months ago (Nov. 8, 2012) |
Published | 12 years, 9 months ago (Nov. 8, 2012) |
Published Online | 12 years, 9 months ago (Nov. 8, 2012) |
@article{Waki_2012, title={Structural and Functional Insights into the HIV-1 Maturation Inhibitor Binding Pocket}, volume={8}, ISSN={1553-7374}, url={http://dx.doi.org/10.1371/journal.ppat.1002997}, DOI={10.1371/journal.ppat.1002997}, number={11}, journal={PLoS Pathogens}, publisher={Public Library of Science (PLoS)}, author={Waki, Kayoko and Durell, Stewart R. and Soheilian, Ferri and Nagashima, Kunio and Butler, Scott L. and Freed, Eric O.}, editor={Krausslich, Hans-Georg}, year={2012}, month=nov, pages={e1002997} }